HMGA2 and ovarian cancer: Gene silencing therapy using siRNA suppressed proliferation and growth of ovarian cancer cell lines overexpressing HMGA2 by cell cycle arrest at G1 phase, and decreased the size of tumor xenografts in athymic nude mice treated with a Hmga2-targeting construct [169].